⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Aspect Biosystems and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Aspect Biosystems
↗Vancouver, Canada
Aspect Biosystems is a Canadian biotechnology company pioneering the development of Bioprinted Tissue Therapeutics (BTTs), a new category of regenerative medicine. The company utilizes a full-stack platform that integrates proprietary AI-powered bioprinting technology, computational design tools, therapeutic cells, and advanced biomaterials to create implantable tissues designed to replace, repair, or supplement biological functions in the body.
The company is focused on addressing serious metabolic and endocrine diseases, including type 1 diabetes, obesity, rare endocrine disorders, and liver disease. By creating allogeneic tissue therapeutics, Aspect aims to deliver functional cures that can restore biological function without the need for long-term immunosuppression.
CLASSIFICATION
SIZE & FINANCIALS
Employees:101-200
Founded:2013
Ownership:private
Status:operating
FUNDING
Stage:Series B
Total Raised:$350M+
Investors:Dimension, Novo Nordisk, Radical Ventures, InBC, Pallasite Ventures, Pangaea Ventures, Rhino Ventures, T1D Fund, Government of Canada, Government of British Columbia
PIPELINE
Stage:Preclinical
Lead Drug Stage:Preclinical
Modalities:Cell therapy, Regenerative medicine, Bioprinted tissue
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Aspect Biosystems US Ltd.
Key Partnerships:Novo Nordisk (focused on diabetes and obesity)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Tamer Mohamed - CEO
Mike Scott - Chief Development Officer
Leela Paris - SVP of Technical Operations
Scientific Founders:Tamer Mohamed, Konrad Walus, Sam Wadsworth, Simon Beyer
Board Members:Andrew Booth, Nancy Krieger, Don Haut, Devyn Smith
LINKS
Website:aspectbiosystems.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Aspect Biosystems. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.